Soodeh Rowhanirad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Soodeh Rowhanirad has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
- Mahnaz Taherianfard
Department of Basic Sciences, School of Veterinary Medicine, Shiraz University, Shiraz, Iran
3 shared publications - Seyed Ali Arefkashfi
Shiraz University, Shiraz, Iran
1 shared publication
Latest Publications
- Open Access
- 30 June 2026
- Published by Brieflands in Journal of Kermanshah University of Medical Sciences
- Vol. 30 (2) , e173063
Brain Serotonin 5-HT2α Receptor Density in Male Rats Can Be Affected by Bisphenol A and Passive Avoidance Learning
Background: Bisphenol A (BPA) may adversely affect the nervous system. Objectives: This study aimed to assess the effects of passive avoidance learning on BPA-induced toxicity, as indicated by serotonin 5-HT2α receptor density in the cerebellum, basolateral amygdala, and hippocampus of male rats. Methods: Thirty male rats (200 - 220 g) were allocated to six experimental groups. BPA was administered orally for 15 consecutive days. Learning and memory performance were assessed using a passive avoidance shuttle-box paradigm. Serotonin 5-HT2α receptor density was evaluated by immunohistochemistry in the selected brain regions. Immunohistochemical labeling was quantified by measuring color parameters using image-analysis software. Results: BPA at both doses reduced 5-HT2α serotonin receptor density in the examined brain structures. Passive avoidance learning mitigated the toxic effects of BPA on 5-HT2α receptor density in these structures. Conclusions: Overall, BPA exposure downregulated 5-HT2α receptors in the hippocampus, amygdala, and cerebellum of male rats, whereas passive avoidance learning and memory were associated with an increased receptor density.
- 30 June 2026
- Published by Brieflands in Journal of Kermanshah University of Medical Sciences
- Vol. 30 (2) , e173063
Open AccessBrain Serotonin 5-HT2α Receptor Density in Male Rats Can Be Affected by Bisphenol A and Passive Avoidance Learning
Background: Bisphenol A (BPA) may adversely affect the nervous system. Objectives: This study aimed to assess the effects of passive avoidance learning on BPA-induced toxicity, as indicated by serotonin 5-HT2α receptor density in the cerebellum, basolateral amygdala, and hippocampus of male rats. Methods: Thirty male rats (200 - 220 g) were allocated to six experimental groups. BPA was administered orally for 15 consecutive days. Learning and memory performance were assessed using a passive avoidance shuttle-box paradigm. Serotonin 5-HT2α receptor density was evaluated by immunohistochemistry in the selected brain regions. Immunohistochemical labeling was quantified by measuring color parameters using image-analysis software. Results: BPA at both doses reduced 5-HT2α serotonin receptor density in the examined brain structures. Passive avoidance learning mitigated the toxic effects of BPA on 5-HT2α receptor density in these structures. Conclusions: Overall, BPA exposure downregulated 5-HT2α receptors in the hippocampus, amygdala, and cerebellum of male rats, whereas passive avoidance learning and memory were associated with an increased receptor density.
- Open Access
- 19 August 2023
- Published by Wiley
Chalcones accelerate the recovery period after cuprizone-induced noxious changes in the C57BL/6 mice model
Multiple sclerosis (MS) is the most common demyelinating disorders of the CNS. Despite advancements in medicine, there remains an absence of an efficient cure without side effects and MS patients suffer from the progressive symptoms. On the other hand, the impact of natural compounds and the mechanisms of their actions in ameliorating neurodegenerative disorders have been poorly known. The current study investigated the effect of Chalcones from Ashitaba (ChA) on accelerating the recovery period in the Cuprizone model. The control group with no Cuprizone or ChA treatment (CNT), Cuprizone-exposed 1 and 2 (CPZ1, CPZ2) groups with 0.2% Cuprizone feeding for five weeks without and with recovery period; respectively. And ChA-treated (Treated1, Treated2) groups received ChA at 300 or 600 mg/kg/day; respectively, for 2 weeks following cuprizone removal. The degree of demyelination in the corpus callosum (CC), impairment of cognitive function, and serum and brain levels of Brain-Derived Neurotrophic Factor (BDNF) and Tumor Necrosis Factor Alpha (TNFα) were evaluated by the histological, Y-maze, and enzyme-linked immunosorbent assay (ELISA) tests, respectively. The results demonstrated that the ChA treatment significantly improved the serum and brain levels of BDNF and the behavioral responses compared to the CPZ-exposed groups. Moreover, the ChA-treated groups had a significant decrease in the serum and brain TNFα levels and the extent of CC demyelination compared to the CPZ-exposed groups. The present study showed that ChA treatment for 2 weeks accelerated remyelination of the CC through suppressing inflammation caused by TNFα and promoting myelination resulted from BDNF.
- 19 August 2023
- Published by Wiley
Open AccessChalcones accelerate the recovery period after cuprizone-induced noxious changes in the C57BL/6 mice model
Multiple sclerosis (MS) is the most common demyelinating disorders of the CNS. Despite advancements in medicine, there remains an absence of an efficient cure without side effects and MS patients suffer from the progressive symptoms. On the other hand, the impact of natural compounds and the mechanisms of their actions in ameliorating neurodegenerative disorders have been poorly known. The current study investigated the effect of Chalcones from Ashitaba (ChA) on accelerating the recovery period in the Cuprizone model. The control group with no Cuprizone or ChA treatment (CNT), Cuprizone-exposed 1 and 2 (CPZ1, CPZ2) groups with 0.2% Cuprizone feeding for five weeks without and with recovery period; respectively. And ChA-treated (Treated1, Treated2) groups received ChA at 300 or 600 mg/kg/day; respectively, for 2 weeks following cuprizone removal. The degree of demyelination in the corpus callosum (CC), impairment of cognitive function, and serum and brain levels of Brain-Derived Neurotrophic Factor (BDNF) and Tumor Necrosis Factor Alpha (TNFα) were evaluated by the histological, Y-maze, and enzyme-linked immunosorbent assay (ELISA) tests, respectively. The results demonstrated that the ChA treatment significantly improved the serum and brain levels of BDNF and the behavioral responses compared to the CPZ-exposed groups. Moreover, the ChA-treated groups had a significant decrease in the serum and brain TNFα levels and the extent of CC demyelination compared to the CPZ-exposed groups. The present study showed that ChA treatment for 2 weeks accelerated remyelination of the CC through suppressing inflammation caused by TNFα and promoting myelination resulted from BDNF.
- Open Access
- 4 July 2023
- Published by Wiley in Brain and Behavior
- Vol. 13 (9) , e3144
The neuroprotective effects of Chalcones from Ashitaba on cuprizone‐induced demyelination via modulation of brain‐derived neurotrophic factor and tumor necrosis factor α
Introduction: Multiple sclerosis (MS) is the most common demyelinating disease of the central nervous system. However, the limitations of available therapeutic strategies are frustrating, both in terms of their low efficacy and multiple side effects. Previous studies showed that natural compounds such as Chalcones possess neuroprotective effects on neurodegenerative disorders. However, few studies have so far been published on the potential effects of Chalcones on treating demyelinating disease. The present study was designed to investigate the effects of Chalcones from Ashitaba (ChA) on cuprizone‐induced noxious changes in the C57BL6 mice model of MS.Methods: The mice received normal diets (Control group: CNT), or Cuprizone‐supplemented diets either without ChA (Cuprizone group: CPZ) or with low or high (300, 600 mg/kg/day) doses of ChA (ChA‐treated groups: CPZ+ChA300/600). Brain‐derived neurotrophic factor (BDNF) and tumor necrosis factor alpha (TNFα) levels, demyelination scores in the corpus callosum (CC), and cognitive impairment were evaluated using the enzyme‐linked immunosorbent assay, histological, and Y‐maze tests, respectively.Results: The findings showed that ChA Co‐treatment significantly reduced the extent of demyelination in the CC and the serum and brain levels of TNFα in the ChA‐treated groups compared to the CPZ group. Besides, treatment with a higher dose of ChA significantly improved the behavioral responses and BDNF levels in the serum and brain of the CPZ+ChA600 group when compared with the CPZ group.Conclusion: The present study provided evidence for the neuroprotective effects of ChA on cuprizone‐induced demyelination and behavioral dysfunction in C57BL/6 mice, possibly by modulating TNFα secretion and BDNF expression.
- 4 July 2023
- Published by Wiley in Brain and Behavior
- Vol. 13 (9) , e3144
Open AccessThe neuroprotective effects of Chalcones from Ashitaba on cuprizone‐induced demyelination via modulation of brain‐derived neurotrophic factor and tumor necrosis factor α
Introduction: Multiple sclerosis (MS) is the most common demyelinating disease of the central nervous system. However, the limitations of available therapeutic strategies are frustrating, both in terms of their low efficacy and multiple side effects. Previous studies showed that natural compounds such as Chalcones possess neuroprotective effects on neurodegenerative disorders. However, few studies have so far been published on the potential effects of Chalcones on treating demyelinating disease. The present study was designed to investigate the effects of Chalcones from Ashitaba (ChA) on cuprizone‐induced noxious changes in the C57BL6 mice model of MS.Methods: The mice received normal diets (Control group: CNT), or Cuprizone‐supplemented diets either without ChA (Cuprizone group: CPZ) or with low or high (300, 600 mg/kg/day) doses of ChA (ChA‐treated groups: CPZ+ChA300/600). Brain‐derived neurotrophic factor (BDNF) and tumor necrosis factor alpha (TNFα) levels, demyelination scores in the corpus callosum (CC), and cognitive impairment were evaluated using the enzyme‐linked immunosorbent assay, histological, and Y‐maze tests, respectively.Results: The findings showed that ChA Co‐treatment significantly reduced the extent of demyelination in the CC and the serum and brain levels of TNFα in the ChA‐treated groups compared to the CPZ group. Besides, treatment with a higher dose of ChA significantly improved the behavioral responses and BDNF levels in the serum and brain of the CPZ+ChA600 group when compared with the CPZ group.Conclusion: The present study provided evidence for the neuroprotective effects of ChA on cuprizone‐induced demyelination and behavioral dysfunction in C57BL/6 mice, possibly by modulating TNFα secretion and BDNF expression.